PubMed

Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future.

PMID: 41493254 · 2026-01-01

R, a, c, h, e, l, , L, , Z, i, e, b, a, r, t, ;, , B, a, r, b, a, r, a, , H, e, r, n, a, n, d, e, z, -, R, o, v, i, r, a, ;, , H, e, m, a, , S, u, n, d, a, r, a, m, ;, , S, a, m, a, n, t, h, a, , G, u, h, a, n, ;, , S, a, r, a, n, y, a, , P, , W, y, l, e, s

학술지Journal of drugs in dermatology : JDD

연도2026-01-01

PMID41493254

초록

Regenerative dermatology is an emerging subspecialty that seeks to restore the structure and function of healthy skin. The United States lacks comprehensive regulatory guidance for regenerative therapies. This review provides an overview of available therapies within regenerative dermatology, outlining the pathways for approval. Articles on regenerative dermatology in PubMed and guidelines issued by the United States Food and Drug Administration (FDA) were reviewed with emphasis on those publish

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.